Recombinant design of the enzymatically active domain of phage Enc34 endolysin to improve its activity against Gram-negative bacteria
2024

Improving Endolysin Activity Against Gram-Negative Bacteria

publication Evidence: moderate

Author Information

Author(s): Kazaka Tatjana, Zrelovs Nikita, Akopjana Inara, Bogans Janis, Jansons Juris, Dislers Andris, Kazaks Andris

Primary Institution: Latvian Biomedical Research and Study Centre

Hypothesis

Can recombinant endolysins be designed to effectively lyse Gram-negative bacteria?

Conclusion

The study found that certain recombinant endolysin constructs can significantly reduce the viable cell count of Gram-negative bacteria.

Supporting Evidence

  • Recombinant endolysins can be designed to lyse Gram-negative bacteria.
  • Some constructs showed significant bactericidal activity against E. coli.
  • The best candidate reduced viable cell counts by more than three-fold.

Takeaway

Scientists are trying to make a special protein that can kill bad bacteria that are hard to treat. They found some versions that work really well!

Methodology

The study involved creating and testing various recombinant endolysin constructs fused with antimicrobial peptides in E. coli to evaluate their lytic activity against Gram-negative bacteria.

Limitations

The constructs did not achieve complete bacterial clearance, and the effectiveness varied among different bacterial strains.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/femsle/fnae103

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication